2m 2m 2m 2m 2m 2m 2m
OLEMA PHARMA (OLMA)
NASDAQ
$8.82-$1.40 (-13.69%)
Price as of Sep 11, 2026 7:59 PM EDT- $894.2MMarket Cap
- 31.53%1-Year Change
- BiotechnologyIndustry
OLEMA PHARMA (OLMA)
$8.82-$1.40 (-13.69%)
OLMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.22 | ||
Change | -$0.47 (-4.40%) | ||
Open | $10.79 | ||
High | $10.86 | ||
Low | $10.18 | ||
Previous Close | $10.69 | ||
Volume | 1,013,488 | ||
30-Day Average Volume | 896,150 | ||
1-Week Change | -4.93% | ||
1-Month Change | -2.01% | ||
1-Year Change | 31.53% | ||
3-Year Change | -17.45% | ||
5-Year Change | -65.12% | ||
Fundamentals | |||
Shares Outstanding | 87.5M | ||
Total Assets | $486.6M | ||
Market Cap | $894.2M | ||
Enterprise Value | $848.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$63.2M | ||
Free Cash Flow | -$45.9M | ||
EBIT | -$63.2M | ||
EBITDA | -$63.1M | ||
Net Working Capital | $416.9M | ||
EPS | -$0.61 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -17 | ||
PEG | 1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue